1.00 / AMA PRA Category 1 CreditTM 1.00 / CNE Contact Hour 1.00 / CPD Credit
This activity is provided by Global Education Group.
This activity is supported by an educational grant from Astellas.
Produced by Haymarket Medical Education (HME)
Overactive bladder (OAB) affects more than 400 million people worldwide, and the number is growing. The condition often has a serious impact on patient quality of life; early recognition of the spectrum and impact of OAB is essential so that therapy can be individualized and initiated as quickly as possible. Available treatments for symptoms encompass both behavioral interventions and pharmacotherapy. Unfortunately, up to 40% of patients have inadequate relief of incontinence with pharmacotherapy, with high discontinuation rates and poor adherence reported for OAB medications.
In this CME activity, 4 international, renowned experts convene to discuss optimal approaches to the identification and treatment of OAB, taking into consideration potential variations in practice among the United States, Europe, and Asia. The panel will discuss practical methods for assessing OAB symptoms and ruling out other potential etiologies, initiating discussions about urinary health with patients who may be reluctant to do, and implementing evidence-based behavioral interventions. The benefits of drawback of the available pharmacotherapies for OAB will be described, as will recent clinical trial data on investigational combination therapy. The need for frequent follow-up, individualized treatment, and good patient-provider communication will be discussed in detail.
Urologists, urogynecologists, obstetrician-gynecologists (ob-gyns), primary care clinicians, nurse practitioners (NPs), physician assistants (PAs), nurses, and other healthcare providers who treat patients with bladder dysfunction
After completing this activity, the participant should be better able to:
Evaluate and diagnose overactive bladder (OAB)
Utilize current therapeutic options for managing OAB, focusing on individualized therapy
Review emerging pharmacologic strategies for OAB management
Provide proper counseling and support to patients with OAB to increase their motivation for treatment-plan adherence
Conflict Of Interest Disclosure Policy
Global Education Group (Global) requires instructors, planners, managers, and other individuals and their spouse/life partners who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Matt Rosenberg, MD (Chair) Medical Director Mid Michigan Health Centers Department of Family Medicine Allegiance Health Systems Jackson, Michigan
Dr. Rosenberg is a consultant and stockholder for OPKD and serves on the Speakers’ Bureau for Astellas.
Professor Christopher Chapple, BSc, MD, FRCS (Urol), FEBU Consultant Urological Surgeon, Royal Hallamshire Hospital Honorary Professor, University of Sheffield Visiting Professor, Sheffield Hallam University Secretary General, European Association of Urology Sheffield, UK
Dr. Chapple is a consultant for Allergan, Astellas, Medtronic, and Recordati. He also receives grant/research support from Allergan, Astellas, and Recordati and serves on the Speakers’ Bureau for Allergan and Astellas.
Professor Marcus Drake, BM, BCh, MA (Cantab), DM (Oxon) Professor of Physiological Urology Senior Lecturer University of Bristol Bristol, UK
Dr. Drake is a speaker for Allergan, Astellas, Ferring, and Pfizer and receives research support from Allergan, Astellas, and Ferring.
Kyu-Sung Lee, MD, PhD Professor, Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine General Director Biomedical Engineering Research Center Samsung Medical Center South Korea
Dr. Lee is a consultant for and receives grant/research support from Astellas Asia-Pacific.
Publishing/Accreditor Staff Disclosures
Andrea Funk, Ashley Marostica, RN, MSN, and Karen Kaufman of Global Education Group have nothing to disclose in regard to commercial interests.
Susan Basilico, Angie Ladas, and Krista Sierra of Haymarket Medical Education have nothing to disclose in regard to commercial interests.
AMA PRA Category 1 Credit(s)TM
Global Education Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Global Education Group designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Contact Hour(s)
Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This educational activity for 1.00 contact hour is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Suggested CPD credit for UK clinicians.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
There is no fee for this activity.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Astellas, Global Education Group, or Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
To obtain credit, a post-test score of 70% or better is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can then access at any time.
If you have any questions relating to the accreditation of this activity, please contact Global Education Group at 303-395-1782 or firstname.lastname@example.org.
Global protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. Global and our joint sponsors will not release personally identifiable information to a third party without the customer’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
Hardware and Software Requirements
A computer with an internet connection
Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required